# Lipocine Announces Financial Results for the Full Year Ended December 31, 2025
Canonical URL: https://biopharmsignal.com/news/LPCN/lipocine-announces-financial-results-for-the-full-year-ended-december-31-2025
Ticker: LPCN
Company: Lipocine Inc.
Source: Lipocine Inc.
Published: 2026-03-10 12:00 EST
Original Source URL: https://ir.lipocine.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-06-04 12:00 EST — [Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154](https://biopharmsignal.com/news/LPCN/lipocine-inc-to-host-virtual-kol-event-highlighting-unmet-needs-in-postpartum-depression-and-the-clinical-profile-of-lpcn-1154) — Source: Lipocine Inc.
- 2026-05-19 12:00 EST — [Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting](https://biopharmsignal.com/news/LPCN/lipocine-announces-lpcn-1154-phase-3-data-accepted-for-oral-presentation-at-2026-ascp-annual-meeting) — Source: Lipocine Inc.
- 2026-05-18 12:00 EST — [Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase](https://biopharmsignal.com/news/LPCN/lipocine-to-present-at-a-g-p-s-annual-virtual-healthcare-company-showcase) — Source: Lipocine Inc.
- 2026-05-07 20:05 EST — [Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026](https://biopharmsignal.com/news/LPCN/lipocine-announces-financial-results-for-the-first-quarter-ended-march-31-2026) — Source: Lipocine Inc.
- 2026-04-02 12:00 EST — [Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression](https://biopharmsignal.com/news/LPCN/lipocine-reports-topline-safety-and-efficacy-results-for-lpcn-1154-in-patients-with-postpartum-depression) — Source: Lipocine Inc.
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)